Videx EC 125mg, 200mg, 250mg and 400mg Gastro-resistant Capsules Ref.[2744] Active ingredients: Didanosine

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2012  Publisher: Bristol-Myers Squibb Pharmaceuticals Limited Uxbridge Business Park Sanderson Road Uxbridge Middlesex UB8 1DH

Product name and form

Videx 125 mg gastro-resistant hard capsule

Videx 200 mg gastro-resistant hard capsule.

Videx 250 mg gastro-resistant hard capsule.

Videx 400 mg gastro-resistant hard capsule.

Pharmaceutical Form

Gastro-resistant capsule, hard.

125 mg: Gastro-resistant capsules are opaque white and embossed in tan with “6671” on one half, and “BMS 125 mg” on the other half.

200 mg: Gastro-resistant capsules are opaque white and embossed in green with “6672” on one half, and “BMS 200 mg” on the other half.

250 mg: Gastro-resistant capsules are opaque white and embossed in blue with “6673” on one half, and “BMS 250 mg” on the other half.

400 mg: Gastro-resistant capsules are opaque white and embossed in red with “6674” on one half, and “BMS 400 mg” on the other half.

Qualitative and quantitative composition

Each gastro-resistant capsule, hard contains 125 mg, 200 mg, 250 mg or 400 mg of didanosine.

For a full list of excipients, see section 6.1.

Active Ingredient Description
Didanosine

Didanosine belongs to a class of medicines called nucleoside analogues or nucleoside reversetranscriptase inhibitors (NRTIs). Intracellularly, didanosine is converted by cellular enzymes to the active metabolite, dideoxyadenosine 5'-triphosphate. Dideoxyadenosine 5'-triphosphate inhibits the activity of HIV-1 reverse transcriptase both by competing with the natural substrate, deoxyadenosine 5'-triphosphate, and by its incorporation into viral DNA causing termination of viral DNA chain elongation.

List of Excipients

Sodium carmellose
Diethyl phthalate
30% methacrylic acid copolymer dispersion (EUDRAGIT L30D-55)
Sodium starch glycolate (Type A)
Talc

Capsule shell:

Gelatin
Sodium laurilsulfate
Titanium dioxide (E171)
Capsule shell imprints (edible ink):
Shellac
Propylene glycol

125 mg:

Potassium hydroxide
Titanium dioxide (E171)
Yellow and red iron oxide (E172)

200 mg:

FD&C Blue #2 Aluminium Lake (E132)
Titanium dioxide (E171)
Yellow iron oxide (E172)

250 mg:

FD&C Blue #2 Aluminium Lake (E132)

400 mg:

Ammonium hydroxide
Simethicone
Red iron oxide (E172)

Pack sizes and marketing

Polyvinyl Chloride/Polyethylene/ACLAR/Aluminium foil blisters with 10 hard capsules per blister card and 3 cards (30 capsules) per carton or with 10 hard capsules per blister card and 6 cards (60 capsules) per carton.

Marketing authorization holder

Bristol-Myers Squibb Pharmaceuticals Limited
Uxbridge Business Park
Sanderson Road
Uxbridge
Middlesex
UB8 1DH

Marketing authorization dates and numbers

Videx EC 125 mg gastro-resistant hard capsule: PL 11184/0083

Videx EC 200 mg gastro-resistant hard capsule: PL 11184/0084

Videx EC 250 mg gastro-resistant hard capsule: PL 11184/0085

Videx EC 400 mg gastro-resistant hard capsule: PL 11184/0086

10/06/2009

Drugs

Drug Countries
VIDEX Estonia, Mexico, United States, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.